MB, Levis & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Hold
187
﹤0.01% 167
2026
Q1
$14.1K Hold
187
0.01% 154
2025
Q4
$11.5K Hold
187
﹤0.01% 159
2025
Q3
$11K Hold
187
﹤0.01% 159
2025
Q2
$10.9K Hold
187
﹤0.01% 190
2025
Q1
$9.29K Hold
187
﹤0.01% 190
2024
Q4
$8.37K Hold
187
﹤0.01% 194
2024
Q3
$8.99K Hold
187
﹤0.01% 197
2024
Q2
$9.52K Hold
187
0.01% 189
2024
Q1
$10.2K Hold
187
0.01% 185
2023
Q4
$10.5K Hold
187
0.01% 183
2023
Q3
$11.5K Hold
187
0.01% 184
2023
Q2
$11K Hold
187
0.01% 193
2023
Q1
$13.8K Hold
187
0.01% 177
2022
Q4
$13.7K Buy
+187
New +$14.8K 0.01% 166

Other funds holding NTR

MB, Levis & Associates's NTR Position: Q2 2026 in Review

MB, Levis & Associates held its Nutrien (NTR) position steady in Q2 2026 at 187 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #167.

MB, Levis & Associates first reported a position in NTR in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.1K in Q1 2026. 135 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • MB, Levis & Associates held 187 shares of Nutrien worth $11.8K as of Q2 2026.
  • MB, Levis & Associates left its Nutrien share count unchanged in Q2 2026.
  • Nutrien made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #167 holding.
  • MB, Levis & Associates first reported a position in Nutrien in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Nutrien position peaked at $14.1K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.